United States · FDA National Drug Code directory
Deflazacort
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 59651-602_a6a915ee-9df8-46ee-a6b7-794834417917
- Product NDC
- 59651-602
- Form
- TABLET
- Composition / generic term
- Deflazacort
- Labeler
- Aurobindo Pharma Limited
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20240209
- Source listing expiry
- 20271231
Source-listed ingredients
- DEFLAZACORT — 36 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 TABLET in 1 BOTTLE (59651-602-30) · 59651-602-30
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →